Stryker claims, in comparison to competitive offerings, the A-PRP prepared using RegenKit-THT provides the highest platelet recovery and viability.
It helps maximize efficiency in the office and OR with a minimal eight minute centrifuge spin time and reduced number of steps.
Stryker Joint Preservation vice president and general manager Matt Moreau said the addition of the RegenKit for PRP therapy to Stryker’s Joint Preservation Biologics portfolio allows them to provide surgeons with this emerging therapy for orthopaedic applications.
